| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0009 |
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.005 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.09 | 0.007 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | -0.092 | 0.007 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | -0.087 | 0.009 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.009 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.02 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.076 | 0.02 |